Narrow-band ultraviolet B treatment for vitiligo, pruritus, and inflammatory dermatoses

Photodermatology Photoimmunology and Photomedicine

Volumn 19, Issue 4, 2003, Pages 164-168

  Yashar, Sharam Samson ^a   Gielczyk, Robert ^a   Scherschun, Lubomira ^a   Lim, Henry W ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Phototherapy; Pruritus; Ultraviolet; Vitiligo

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; THYROTROPIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CUTANEOUS T CELL LYMPHOMA; FEMALE; HUMAN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; PHOTOTHERAPY; PRIORITY JOURNAL; PRURITUS; PSORIASIS; PUVA; RADIATION INJURY; RETROSPECTIVE STUDY; SCHOOL CHILD; SKIN INFLAMMATION; SPECTRAL SENSITIVITY; THYROTROPIN BLOOD LEVEL; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION; VITILIGO;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PRURITUS; RETROSPECTIVE STUDIES; SKIN DISEASES; TREATMENT OUTCOME; ULTRAVIOLET THERAPY; VITILIGO;

EID: 0042925518     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0781.2003.00039.x     Document Type: Article

References (30)

1. Reynolds NJ, Franklin V, Gray JC, Diffey BL, Farr PM. Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial. Lancet 2001; 357: 2012-2016.
2. Coven TR, Burack LH, Keogh M, Ozawa M, Krueger JG. Narrowband UV-B produces superior clinical and histopathological resolution of psoriasis in patients compared with broadband UV-B. Arch Dermatol 1997; 133: 1514-1522.
3. Gathers RC, Scherschun L, Malick F, Fivenson DP, Lim HW. Narrowband UVB phototherapy for early-stage mycosis fungoides. J Am Acad Dermatol 2002; 47: 191-197.
4. Bilsland D, George SA, Gibbs NK, Aitchison T, Johnson BE, Ferguson J. A comparison of narrow band phototherapy (TL-01) and photochemotherapy (PUVA) in the management of polymorphic light eruption. Br J Dermatol 1993; 129: 708-712.
5. Njoo MD, Westerhof W. Vitiligo. Pathogenesis and treatment. Am J Clin Dermatol 2001; 2: 167-181.
6. Scherschun L, Kim JJ, Lim HW. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol 2001; 44: 999-1003.
7. Gordon PM, Diffey BL, Matthews JN, Farr PM. A randomized comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis. J Am Acad Dermatol 1999; 41: 728-732.
8. Moretti S, Spallanzani A, Amato L, Hautmann G, Gallerani I, Fabbri P. Vitiligo and epidermal microenvironment: possible involvement of keratinocyte-derived cytokines. Arch Dermatol 2002; 138: 273-274.
9. Van Den Wijngaard RM, Asghar SS, Pijnenborg AC, Tigges AJ, Westerhof W, Das PK. Aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor, in the involved epidermis of patients with vitiligo. Br J Dermatol 2002; 146: 80-87.
10. Van Den Wijngaard R, Wankowicz-Kalinska A, Pals S, Weening J, Das P. Autoimmune melanocyte destruction in vitiligo. Lab Invest 2001; 81: 1061-1067.
11. Yee C, Thompson JA, Roche P et al. Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of T cell-mediated vitiligo. J Exp Med 2000; 192: 1637-1644.
12. Szepietowski JC, Morita A, Tsuji T. Ultraviolet B induces mast cell apoptosis: a hypothetical mechanism of ultraviolet B treatment for uraemic pruritus. Med Hypotheses 2002; 58: 167-170.
13. Enk CD, Sredni D, Blauvelt A, Katz SI. Induction of IL-10 gene expression in human keratinocytes by UVB exposure in vivo and in vitro. J Immunol 1995; 154: 4851-4856.
14. Ozawa M, Ferenczi K, Kikuchi T et al. 312-Nanometer ultraviolet B light induces apoptosis of T cells within psoriatic lesions. J Exp Med 1999; 189: 711-718.
15. Collins P, Ferguson J. Narrow-band UVB (TL-01) phototherapy: an effective preventative treatment for the photodermatoses. Br J Dermatol 1995; 132: 956-963.
16. Pathak MA, Fanselow DL. Photobiology of melanin pigmentation: dose/response of skin to sunlight and its contents. J Am Acad Dermatol 1983; 9: 724-733.
17. Simon JC, Tigelaar RE, Bergstresser PR, Edelbaum D, Cruz PD Jr. Ultraviolet B radiation converts Langerhans cells from immunogenic to tolerogenic antigen-presenting cells. Induction of specific clonal anergy in CD4+ T helper 1 cells. J Immunol 1991; 146: 485-491.
18. Simon JC, Cruz PD Jr, Bergstresser PR, Tigelaar RE. Low dose ultraviolet B-irradiated Langerhans cells preferentially activate CD4+ cells of the T helper 2 subset. J Immunol 1990; 145: 2087-2091.
19. Vermeer M, Streilein JW. Ultraviolet B light-induced alterations in epidermal Langerhans cells are mediated in part by tumor necrosis factor-alpha. Photodermatol Photoimmunol Photomed 1990; 7: 258-265.
20. Schwarz T. Photoimmunosuppression. Photodermatol Photoimmunol Photomed 2002; 18: 141-145.
21. Swartz RP. Role of UVB-induced serum factor(s) in suppression of contact hypersensitivity in mice. J Invest Dermatol 1984; 83: 305-307.
22. Alora MB, Taylor CR. Narrow-band (311 nm) UVB phototherapy: an audit of the first year's experience at the Massachusetts General Hospital. Photodermatol Photoimmunol Photomed 1997; 13: 82-84.
23. Tauscher AE, Fleischer AB, Phelps KC, Feldman SR. Psoriasis and pregnancy. J Cutan Med Surg 2002; 11: 73-75.
24. The British Photodermatology Group An appraisal of narrowband (TL-01) UVB phototherapy. British Photodermatology Group Workshop Report (April 1996). Br J Dermatol 1997; 137: 327-330.
25. Njoo MD, Bossuyt PM, Westerhof W. Management of vitiligo. Results of a questionnaire among dermatologists in The Netherlands. Int J Dermatol 1999; 38: 866-872.
26. Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol 2000; 42: 245-253.
27. Handa S, Pandhi R, Kaur I. Vitiligo: a retrospective comparative analysis of treatment modalities in 500 patients. J Dermatol 2001; 28: 461-466.
28. Handa S, Kaur I. Vitiligo: clinical findings in 1436 patients. J Dermatol 1999; 26: 653-657.
29. Zetting G, Tanew A, Fischer G, Mayr W, Dudczak R, Weissel M. Autoimmune diseases in vitiligo: do anti-nuclear antibodies decrease thyroid volume? Clin Exp Immunol 2003; 131: 347-354.
30. Grunnet I, Howitz J, Reymann F, Schwartz M. Vitiligo and pernicious anemia. Arch Dermatol 1970; 101: 82-85.